Hazra, M. 2022. A rational pharmacovigilance safety appraisal of topical pefloxacin 0.3% ophthalmological drops in bacterial conjunctivitis, in global multi-centre tertiary care hospitals. International Journal of Basic & Clinical Pharmacology. 11, 4 (Jul. 2022), 302–307. DOI:https://doi.org/10.18203/2319-2003.ijbcp20221595.